Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in mice
David R. Martinez, Alexandra Schaefer, S. Gobeil, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity
S. Gobeil, Katarzyna Janowska, Shana McDowell, et al.
Science (2021) Vol. 373, Iss. 6555
Open Access | Times Cited: 395
Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants
Matthew McCallum, Alexandra C. Walls, Kaitlin R. Sprouse, et al.
Science (2021) Vol. 374, Iss. 6575, pp. 1621-1626
Open Access | Times Cited: 285
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
David R. Martinez, Alexandra Schäfer, Sarah R. Leist, et al.
Science (2021) Vol. 373, Iss. 6558, pp. 991-998
Open Access | Times Cited: 177
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Alexandra C. Walls, Marcos C. Miranda, Alexandra Schäfer, et al.
Cell (2021) Vol. 184, Iss. 21, pp. 5432-5447.e16
Open Access | Times Cited: 161
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
Young‐Jun Park, Anna De Marco, Tyler N. Starr, et al.
Science (2022) Vol. 375, Iss. 6579, pp. 449-454
Open Access | Times Cited: 141
SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment
Dapeng Li, Gregory D. Sempowski, Kevin O. Saunders, et al.
Annual Review of Medicine (2021) Vol. 73, Iss. 1, pp. 1-16
Closed Access | Times Cited: 130
SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines
John E. Bowen, Young‐Jun Park, Cameron Stewart, et al.
Science Immunology (2022) Vol. 7, Iss. 78
Open Access | Times Cited: 70
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope
Laura A. VanBlargan, Lucas J. Adams, Zhuoming Liu, et al.
Immunity (2021) Vol. 54, Iss. 10, pp. 2399-2416.e6
Open Access | Times Cited: 94
Emerging SARS-CoV-2 Variants: Genetic Variability and Clinical Implications
Aakriti Dubey, Shweta Choudhary, Pravindra Kumar, et al.
Current Microbiology (2021) Vol. 79, Iss. 1
Open Access | Times Cited: 71
Molecular basis of immune evasion by the delta and kappa SARS-CoV-2 variants
Matthew McCallum, Alexandra C. Walls, Kaitlin R. Sprouse, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 52
A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2
Kang Wang, Yunlong Cao, Yunjiao Zhou, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 46
Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design
Daniel Ellis, Natalie Brunette, Katharine H. D. Crawford, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 45
Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors
Daichao Wu, A. V. Kolesnikov, Rui Yin, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 36
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
William R. Strohl, Zhiqiang Ku, Zhiqiang An, et al.
BioDrugs (2022) Vol. 36, Iss. 3, pp. 231-323
Open Access | Times Cited: 32
A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
Pengfei Wang, Ryan G. Casner, Manoj S. Nair, et al.
Emerging Microbes & Infections (2021) Vol. 11, Iss. 1, pp. 147-157
Open Access | Times Cited: 35
Host Genetic Variation Impacts SARS-CoV-2 Vaccination Response in the Diversity Outbred Mouse Population
Marta C Cruz Cisneros, Elizabeth J. Anderson, Brea K. Hampton, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 103-103
Open Access | Times Cited: 4
Rapid test to assess the escape of SARS-CoV-2 variants of concern
Jacob T. Heggestad, Rhett J. Britton, David Kinnamon, et al.
Science Advances (2021) Vol. 7, Iss. 49
Open Access | Times Cited: 25
SARS-CoV-2 spike conformation determines plasma neutralizing activity
John E. Bowen, Alexandra C. Walls, Anshu Joshi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 25
A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants
Sisi Shan, Chee Keng Mok, Shuyuan Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 21
A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants
Ali A. Rabaan, Abbas Al Mutair, Khalid Hajissa, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1655-1655
Open Access | Times Cited: 15
Current development of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies (Review)
Tong Zhang, Di Yang, Liang Tang, et al.
Molecular Medicine Reports (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 2
Dermal Delivery of a SARS-CoV-2 Subunit Vaccine Induces Immunogenicity against Variants of Concern
Christopher L. D. McMillan, Armira Azuar, Jovin J. Y. Choo, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 578-578
Open Access | Times Cited: 12
A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variants
Naphak Modhiran, Simon Lauer, Alberto A. Amarilla, et al.
iScience (2023) Vol. 26, Iss. 7, pp. 107085-107085
Open Access | Times Cited: 7
Chimeric spike mRNA vaccines protect against Sarbecoviruschallenge in mice
David R. Martinez, Alexandra Schäfer, Sarah R. Leist, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 17
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
Young‐Jun Park, Anna De Marco, Tyler N. Starr, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top